Organ and tissue safety workshop 2007: Advances and challenges

Cell and Tissue Banking

Volumn 10, Issue 3, 2009, Pages 271-280

  Fishman, Jay A ^a   Strong, D Michael ^b   Kuehnert, Matthew J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adverse events; Cornea; Infectious disease transmission; Organs; Surveillance; Tissue; Transplantation

Indexed keywords

ALLOGRAFT; AWARENESS; BLOOD ANALYSIS; CONFERENCE PAPER; DISEASE TRANSMISSION; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MEDICAL EXPERT; MICROBIOLOGICAL EXAMINATION; NUCLEIC ACID ANALYSIS; ORGAN DONOR; ORGAN PRESERVATION; PATIENT SAFETY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES; WORKSHOP;

DISEASE TRANSMISSION, INFECTIOUS; DONOR SELECTION; HUMANS; TISSUE BANKS; TISSUE DONORS; TISSUE TRANSPLANTATION;

EID: 67651113862     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-008-9114-z     Document Type: Conference Paper

References (40)

1. AABB (2008a) http://www.aabb.org/Content/Programs_and_Services/ Data_Center/West_Nile_Virus/08wnv.htm. Accessed 28 July 2008
2. AABB (2008b) http://www.aabb.org/Content/Programs_and_Services/ Data_Center/Chagas. Accessed 28 July 2008
3. Basset D, Faraut F, Marty P, Dereure J, Rosenthal E, Mary C, Pratlong F, Lachaud L, Bastien P, Dedet JP (2005) Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 7:1370-1375. doi: 10.1016/j.micinf.2005.06.002
4. Centers for Disease Control and Prevention (2001) Chagas disease after organ transplantation - United States, 2001. MMWR 51(10):210-212
5. Centers for Disease Control and Prevention (2002) West Nile virus infection in organ donor and transplant recipients - Georgia and Florida. MMWR 51:790
6. Centers for Disease Control and Prevention (2005) West Nile virus infections in organ transplant recipients - New York and Pennsylvania, August-September. MMWR 54(40):1021-1023
7. Centers for Disease Control, Prevention (2008) Transplantation-transmitted tuberculosis - Oklahoma, Texas, 2007. MMWR 57(13):333-336
8. Cortes NJ, Afzali B, MacLean D, Goldsmithe DJ, O'Sullivan H, Bingham J, Lewis DA, MacMahon E, Tong CY, Koffman G (2006) Transmission of syphilis by organ transplantation. Am J Transplant 6:2497-2499. doi: 10.1111/ j.1600-6143.2006.01461.x
9. D'Albuquerque LA, Gonzalez AM, Filho HL, Coopstein JLM, Larrea FIS, Mansero JMP, Peron G, Ribeiro MAF, de Oliveira e Silva A (2007) Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant 7(3):680-684. doi: 10.1111/ j.1600-6143.2007.01663.x
10. Eastlund T, Strong DM (2004) Infectious disease transmission through tissue transplantation. In: (Phillips GO (ed) Advances in tissue banking, vol 7. World Scientific Publishing Company, Singapore, pp 51-131
11. Fischer SA, Graham MB, Kuehnert MJ et al (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354:2235-2249. doi: 10.1056/NEJMoa053240
12. Fishman JA (2007) Infection in solid organ transplant recipients. N Engl J Med 357:2601-2614. doi: 10.1056/NEJMra064928
13. Fishman JA (2008) Rapporto dell - OMS sulla valutazione del programma nazionale trapianti in Italia (gennaio 2008). Trapianti 12(2):37-53
14. Fishman JA, Greenwald MA, Kuehnert MD (2007) Enhancing transplant safety: A new era in the microbiologic evaluation of organ donors? Am J Transplant 7:2652-2654. doi: 10.1111/j.1600-6143.2007.02023.x
15. Food and Drug Administration (2005) Procedures for handling adverse reaction reports related to "361" human cells, tissues, and cellular and tissue-based products (HCT/Ps). http://www.fda.gov/cber/ regsopp/8508.htm. Accessed 28 July 2008
16. Gandhi MJ, Strong DM (2007) Donor derived malignancy: A review. Cell Tissue Bank 8(4):267-286. doi: 10.1007/s10561-007-9036-1
17. Guaraldi G, Cocchi S, Codeluppi M, Pecorari M, Barozzi P, Gennari W, Bagni A, Bosco R, Vallerini D, Di Benedetto F, Masetti M, Portolani M, Torelli G, Luppi M (2006) Giant cell hepatitis following primary infection with HHV-6 variant A, transmitted from the donor, in a liver transplant recipient latently infected with HHV-6 variant B. J Clin Virol 37(1):S108. doi: 10.1016/S1386-6532(06)70059-2
18. Hassan SS, Wilhelmus KR, Dahl P, Davis GC, Roberts RT, Ross KW, Varnum BH, Medical Review Subcommittee of the Eye Bank Association of America (2008) Infect dis risk factors corneal graft donors. Arch Ophthalmol 126:235-239
19. Hellenbrand W, Meyer C, Rasch G, Steffens I, Ammon A (2005) Cases of rabies in Germany following organ transplantation. Euro Surveill 10:E050224
20. Humar A, Fishman JA (2008) Donor-derived infection: Old problem, new solutions? Am J Transplant 8(6):1087-1088. doi: 10.1111/ j.1600-6143.2008.02246.x
21. JAMA (2005) Lymphocytic choriomeningitis virus infection in organ transplant recipients-Massachusetts, Rhode Island, 2005. JAMA 294(2):173-174. doi: 10.1001/jama.294.2.173
22. Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, Jernigan DB, Archibald LK (2004) Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 350:2564-2571. doi: 10.1056/NEJMoa023222
23. Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Cilia J, Jarvis WR (1998) Candida albicans endocarditis associated with a contaminated aortic valve allograft: Implications for regulation of allograft processing. Clin Infect Dis 27(4):688-691. doi: 10.1086/514944
24. Kumar D, Drebot MA, Wong SJ et al (2004) A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 4:1883-1888. doi: 10.1111/j.1600-6143.2004.00592.x
25. Larsen M, Habermann TM, Bishop AT, Shin AY, Spinner RJ (2007) Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case report. J Neurosurg 106:924-928. doi: 10.3171/jns.2007.106.5.924
26. Lee EH, Ferguson D, Jernigan D, Greenwald M, Cote T, Bos JE, Guarner J, Zaki S, Schuchat A, Beall B, Srinivasan A (2007) Invasive group-a streptococcal infection in an allograft recipient. A case report. J Bone Joint Surg Am 89:2044-2047. doi: 10.2106/JBJS.F.01594
27. Martin-Davilla P, Fortun J, Lopez-Velez R, Norman F, de Oca MM, Zamarron P, Gonzalez MI, Moreno A, Fumarola T, Garrido G (2008) Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Rev Microbiol 21:60-98. doi: 10.1128/CMR.00021-07
28. OPTN (2007) OPTN/UNOS Statement regarding HIV and Hepatitis C Transmission through organ transplantation. Available via OPTN. http://www.optn.org/news/newsDetail.asp?id=977. Accessed 1 Sept 2008
29. Palacios G, Druce J, Du L et al (2008) A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 358:991-998. doi: 10.1056/NEJMoa073785
30. Reuters (2007) Italian doctors transplant HIV infected organs. Available via Reuters.com. http://www.reuters.com/article/healthNews/ idUSTON10393420070221. Accessed 28 July 2008
31. Schweitzer EJ, Perencevich EN, Philosophe B, Bartlett ST (2007) estimated benefits of transplantation of kidneys from donors at increased risk for HIV or Hepatitis C Infection. Am J Transplant 7:1515-1525. doi: 10.1111/j.1600-6143.2007.01769.x
32. Srinivasan A, Burtin EC, Kuehnert MJ, Rupprecht C, Sutker W, Ksiazek TG, Paddock CD, Guarner J, Shieh WJ, Goldsmith C, Hanlon CA, Zoretic J, Fischbach B, Niezgoda M, El-Feky WH, Orciari L, Sanchez EQ, Likos A, Klintmalm GB, Cardo D, Leduc J, Chamberland ME, Jernigan DB, Zaki SR (2005) Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 352:1103-1111. doi: 10.1056/ NEJMoa043018
33. Stramer SL, Caglioti S, Strong DM (2000) NAT of the United States and Canadian blood supply. Transfusion 50:1165-1168. doi: 10.1046/ j.1537-2995.2000.40101165.x
34. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP (2004) Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 351(8):760-768
35. Strong DM, Nelson K, Pierce M, Stramer SL (2005) Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid. Cell Tissue Bank 6:255-262. doi: 10.1007/s10561-005-2834-4
36. Trotter JF (2008) Infectious disease risk factors of corneal graft donors. Arch Ophthalmol 126(2):235-239. doi: 10.1001/ archophthalmol.2007.45
37. Tugwell BD, Patel PR, Williams IT, Hedberg K, Chai F, Nainan OV, Thomas AR, Woll JE, Bell BP, Cieslak PR (2005) Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 143:648-654
38. Wang S, Zinderman C, Wise R, Braun M (2007) Infections and human tissue transplants: Review of FDA MedWatch reports 2001-2004. Cell Tissue Bank 8(3):211-219. doi: 10.1007/s10561-007-9034-3
39. Warren J (2006) BTS stolen body parts scandal generating gruesome headlines, fears of infection; NY grand jury meeting Transplant News, Jan 13
40. Zou S, Dodd RY, Stramer SL, Strong DM (2004) Tissue Safety Study Group. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 351:751-759. doi: 10.1056/NEJMoa032510